Disclosure Panels Details Page
Occult Primary Panel - Disclosures as of 06/30/2017
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Mary Anne Bergman | None | None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | ✔ |
| Daniel Bowles MD | None | None | None | None | ✔ |
| Sunandana Chandra MD, MS | None | Bristol Myers Squibb EMD Serono |
None | None | - |
| Mihaela Cristea MD | None | None | None | None | - |
| Jeremiah Deneve DO | None | None | None | None | - |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Keith Eaton MD, PhD | Mirati Therapuetics Pfizer Inc. Resolution Bioscience |
None | None | None | ✔ |
| David Ettinger MD, FACP, FCCP | Golden Biotechnology Corp | ARIAD Pharmaceuticals, Inc. BeyondSpring Pharmaceuticals Boehringer Ingelheim GmbH Bristol Myers Squibb Eli Lilly and Company EMD Serono Genentech, Inc. Helsinn Therapeutics Helsinn Therapeutics (US), Inc. Heron Therapeutics McGivney Global Consultants Trovagene Trovagene, Inc. |
None | None | ✔ |
| David Gierada MD | None | None | None | None | ✔ |
| G. Weldon Gilcrease MD | None | None | None | None | ✔ |
| Kelly Godby MD | None | None | None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | ✔ |
| Angela Jain MD | None | None | None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Christina Kong MD | None | None | None | None | ✔ |
| Jeremy Kortmansky MD | None | None | None | None | ✔ |
| Renato Lenzi MD | None | None | None | None | ✔ |
| Sam Lubner MD | None | None | None | None | ✔ |
| Martin Mahoney MD, PhD | None | Merck & Co., Inc. Pfizer Inc. |
Merck & Co., Inc. Pfizer Inc. sanofi-aventis U.S. |
None | - |
| Joan McClure MS | None | None | None | None | ✔ |
| Ndiya Ogba PhD | None | None | None | None | ✔ |
| John Phay MD | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | ✔ |
| Asif Rashid MD | None | None | None | None | ✔ |
| Kerry Reynolds MD | None | None | None | None | ✔ |
| Leonard Saltz MD | Taiho Pharmaceuticals Co., Ltd. | None | None | None | ✔ |
| Jillian Scavone PhD | None | None | None | None | - |
| Richard Schwab MD | OBI Pharma | None | None | None | - |
| Marc Shapiro MD | None | AIM Specialty Health | None | None | - |
| Chanjuan Shi MD, PhD | None | None | None | None | ✔ |
| Jack Skinner PhD | None | None | None | None | ✔ |
| Jeffrey Smerage MD, PhD | None | Michigan Oncology Clinical Treatment Pathways Program | None | None | - |
| Marvaretta Stevenson MD | None | None | None | None | ✔ |
| Amy Tuten PharmD, BCOP | None | None | None | None | - |
| Gauri Varadhachary MD | Apocell Merck & Co., Inc. Momenta Pharmaceuticals, Inc Rexahn Pharmaceuticals |
Celgene Corporation MedImmune Inc. Merrimack Pharmaceuticals |
None | None | ✔ |
| Harry Yoon MD | Boston Biomedical Eli Lilly and Company Genentech, Inc. Merck & Co., Inc. Merrimack |
LSK BioPharma Merrimack |
None | None | - |
| Matthew Yurgelun MD | Myriad Genetic Laboratories, Inc. | None | None | None | ✔ |
| Jonathan Zager MD | Amgen Inc. Castle Biosciences Delcath Systems Provectus |
Amgen Inc. Delcath Systems |
Castle Biosciences Delcath Systems |
None | - |
| Weining Zhen MD | None | None | None | None | ✔ |